Corporate Information And Statement Of Ifrs Compliance [Abstract]

Alligator Bioscience - Filing #679585

Concept	As at 2023-12-31	2023-01-01 to 2023-12-31	As at 2022-12-31
Corporate information and statement of IFRS compliance [abstract]
Name of reporting entity or other means of identification	—	Alligator Bioscience AB	—
Domicile of entity	—	Sverige	—
Legal form of entity	—	ett publikt aktiebolag	—
Country of incorporation	—	i Sverige m	—
Address of entity's registered office	—	Medicon Village, 223 81 Lund, Sverige.	—
Principal place of business	—	säte i Lund.	—
Description of nature of entity's operations and principal activities	—	klas	—
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [text block]	—	—	—
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [abstract]
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [line items]
Current trade receivables	2,000 SEK	—	13 930 SEK
Current trade payables	21 273 SEK	—	13 343 SEK
Disclosure of material accounting policy information [text block]	—	2. Betydande redovisningsprinciper	—
Disclosure of assets and liabilities with significant risk of material adjustment [text block]	—	3. Viktiga uppskattningar och bedömningar	—
Disclosure of objectives, policies and processes for managing capital [text block]	—	5. Kapitalhantering	—